How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

  • Question on Document

    Do you agree NICE should focus on guidance production and maintenance on priority areas (section 5) and these should be reviewed periodically to ensure NICE is supporting what the health and care system needs? If you disagree, please give reason and rationale.

  • Question on Document

    Do you agree that NICE should be transparent about its remit (section 3.12, section 6.1.1 and 6.2)? If you disagree, please give reason and rationale.

  • Question on Document

    Do you think the new process and consideration factors for NICE to propose topics to the Secretary of State for NHAP are robust and transparent (section 4 and Annex A)? If you disagree, please give reason and rationale. Are there any other factors NICE should include to consider?

  • Question on Document

    Do you think the new merged single-stage prioritisation framework is more streamlined and efficient for topic selection? If you disagree, please give reason and rationale.

NICE-wide topic prioritisation: the manual

Open for comments Open until   Request commenting lead permission

We have updated this service so that members of the same organisation can now collaborate on a joint online response.

Read our blog to learn more.

10 Communicating prioritisation and routing decisions

All prioritisation decisions are shared with the Department of Health and Social Care (DHSC) and NHS England (NHSE) before publication on the NICE website.

NICE seeks a formal referral from the DHSC or NHSE for new topics prioritised by the board.

The notifier (and person who suggested the topic to NICE, if these people are different) are informed about the prioritisation and routing decision.

NICE prioritisation board decisions are published on the NICE website with the:

  • topic name and identification number

  • decision (selected, further information needed, not selected with possible outcomes in section 8.2.3)

  • brief rationale for the decision

  • date of the decision.

Topics that are not prioritised can be reconsidered if the NICE team is made aware of new information that addresses the reasons for non-selection, and more than 6 months have elapsed since the original decision was published.

Once a topic has been selected, it is scheduled for NICE guidance development, subject to formal referral from the DHSC or NHSE in accordance with Regulation 5 of the National Institute for Health and Care Excellence (Constitution and Functions) and the Health and Social Care Information Centre (Functions) Regulations 2013.

Topics on medicines that do not have UK regulatory approval or that have not been launched in the UK are scheduled for development so that the guidance publishes alongside or as early as possible after approval and launch. Topics that already have UK regulatory approval and have been launched in the UK are scheduled for development as soon as is practical. Scheduling topics for development takes into account the existing guidance development schedule and external factors such as ongoing studies to generate relevant evidence.